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Background: Longitudinal monitoring studies of persistent organic pollutants (POPs) in 
human populations are important to better understand changes with time and age, and for future 
predictions.
oBjectives: We sought to describe serum POP time trends on an individual level, investigate age–
period–cohort effects, and compare predicted polychlorinated biphenyl (PCB) concentrations to 
measured values.
Methods: Serum was sampled in 1979, 1986, 1994, 2001, and 2007 from a cohort of 53 men 
in Northern Norway and analyzed for 41 POPs. Time period, age, and birth cohort effects were 
assessed by graphical analyses and mixed-effect models. We derived the predicted concentrations of 
four PCBs for each sampling year using the CoZMoMAN model.
results: The median decreases in summed serum POP concentrations (lipid-adjusted) in 1986, 
1994, 2001, and 2007 relative to 1979 were –22%, –52%, –54%, and –68%, respectively. We 
observed substantial declines in all POP groups with the exception of chlordanes. Time period 
(reflected by sampling year) was the strongest descriptor of changes in PCB-153 concentra-
tions. Predicted PCB-153 concentrations were consistent with measured concentrations in the 
study population.
conclusions: Our results suggest substantial intraindividual declines in serum concentrations of 
legacy POPs from 1979 to 2007 in men from Northern Norway. These changes are consistent with 
reduced environmental exposure during these 30 years and highlight the relation between historic 
emissions and POP concentrations measured in humans. Observed data and interpretations are 
supported by estimates from the CoZMoMAN emission-based model. A longitudinal decrease in 
concentrations with age was evident for all birth cohorts. Overall, our findings support the rel-
evance of age–period–cohort effects to human biomonitoring of environmental contaminants.
citation: Nøst TH, Breivik K, Fuskevåg OM, Nieboer E, Odland JØ, Sandanger TM. 2013. 
Persistent organic pollutants in Norwegian men from 1979 to 2007: intraindividual changes, age–
period–cohort effects, and model predictions. Environ Health Perspect 121:1292–1298; http://
dx.doi.org/10.1289/ehp.1206317
Introduction
The use of persistent organic pollutants 
(POPs) in agriculture and industry increased 
markedly beginning in the 1930s [Arctic 
Monitoring and Assessment Programme 
(AMAP) 2004]. As concerns for the detrimen-
tal effects of POPs on the environment and 
human health increased, measures to reduce 
or eliminate the production and use of POPs 
were initiated in many countries from the 
1970s onward (AMAP 1998). Consequently, 
global emissions of legacy POPs have largely 
followed the same trends. Reduced use and 
emissions of legacy POPs were followed by 
declining POP concentrations in air and biota 
(e.g., Hung et al. 2010; Rigét et al. 2010), 
which has led to reduced human exposure. 
Accordingly, declining concentrations of most 
banned compounds have been reported in 
the few available human longitudinal POP 
studies (Hagmar et al. 2006; Hovinga et al. 
1992; Høyer et al. 2000; Tee et al. 2003; Vo 
et al. 2008).
POP concentrations have frequently been 
reported to be positively associated with age 
(Hardell et al. 2010; Rylander et al. 1997; 
Wolff et al. 2005) and to birth cohorts 
(Bjerregaard et al. 2001; Perry et al. 2005; 
Wolff et al. 2007) in human cross-sectional 
studies. In such studies, age and birth cohort 
effects are confounded (Glenn 2003; Quinn 
and Wania 2012). In longitudinal epidemio-
logic studies, age effects reflect differences 
in risk factors between age groups, period 
effects reflect temporal changes in factors that 
affect all individuals in a population, and 
birth cohort effects reflect generation- specific 
influences (Glenn 2003; Holford 1991; 
Palmore 1978). The interdependence of age, 
period, and cohort effects produces mutual 
confounding in time-trend studies. This has 
previously not been considered in empirical 
studies of POP time trends.
A person’s lifetime environmental expo-
sure to any POP (i.e., the intensity and dura-
tion of individual environmental exposure) 
depends on birth year relative to the time of 
peak environmental concentrations. Increasing 
age is associated with physiological changes 
(e.g., changes in body composition and 
metabolism) and changes in dietary patterns 
that may influence both the intake and the 
elimination of POPs. Environmental expo-
sures and dietary habits also differ among birth 
cohorts and contribute to differences in the 
duration and intensity of exposures to spe-
cific POPs. Finally, periodic patterns reflect 
changes in environmental POP concentrations 
related to historic emissions and environmen-
tal persistence, in addition to temporal trends 
in dietary intakes.
The present study was based on five 
repeated measurements of serum POPs con-
centrations during 1979–2007 in a cohort of 
53 men from Northern Norway. Our primary 
aims were to describe intraindividual changes 
in POP concentrations and composition 
and to investigate age–period–cohort (APC) 
effects. In addition, we compared measured 
POPs concentrations and observed APC pat-
terns to predictions based on the time-variant 
CoZMoMAN model (Breivik et al. 2010). 
Use of emission-based mechanistic modeling 
in combination with the unique empirical 
data available for the study population pro-
vides insight into the relationship between 
environmental emissions and observed 
 concentrations in humans.
Subjects and Methods
Study population and subject selection. Five 
repeated population surveys in the Tromsø 
study (summarized by Jacobsen et al. 2012) 
took place in the municipality of Tromsø 
in Northern Norway, in 1979, 1986–1987 
(hereafter referred to as 1986), 1994–1995 
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(1994), 2001, and 2007–2008 (2007). Of 60 
randomly selected men, 53 had sufficient sam-
ple volumes in ≥ 3 sampling years (11 miss-
ing samples were randomly distributed across 
sampling years). In total, the present analyses 
comprised 254 serum samples from 53 men. 
Birth year and body mass index information 
was extracted from questionnaires. The study 
was approved by the Regional Committees 
for Medical Research Ethics. Participation 
was voluntary and all participants provided 
informed consent. Serum samples were stored 
at –70°C until analysis.
Analytical methodology. All contaminant 
analyses were performed during 2011 at the 
laboratories of the Norwegian Institute for 
Air Research (NILU) and the University 
Hospital of Northern Norway (UNN). 
Serum samples were extracted and analyzed 
for polychlorinated biphenyls (PCBs) and 
organochlorine pesticides [chlordanes, hexa-
chlorohexanes (HCHs), hexachlorobenzene 
(HCB), 1,1,1-trichloro-2,2-bis(p-chloro-
phenyl)ethane (p,p´-DDT) and its metabo-
lites (DDTs), and toxaphenes]. A complete 
list of the individual POPs is provided in 
Supplemental Material, Table S1.
Extraction and cleanup. Methods for 
extraction and cleanup were modified from 
Sandanger et al. (2003, 2007). We weighed 
serum samples [mean 0.92 g (range, 0.24–
1.12 g)] and added 26 13C-labeled internal 
standards, deionized water saturated with 
ammonium sulfate (1 mL), methanol (2 mL), 
and hexane (6 mL) to the samples. Each 
serum mixture was vortexed and shaken for 
1 hr. The samples were centrifuged (1,200 
rpm, 6 min) in an Eppendorf 5702R cen-
trifuge (Eppendorf, Hamburg, Germany), 
and the supernatant hexane was pipetted off. 
The extraction protocol was repeated with 
6 mL of hexane, and the hexane supernatants 
were combined and evaporated to 0.5 mL in 
a heated vacuum evaporation unit. We per-
formed subsequent cleanup using solid-phase 
extraction columns (Florisil, 1 g,  deactivated) 
in an automated liquid handling system. 
Each column was prewashed with hexane/ 
dichloromethane (DCM) (12 mL; 9:1 wt/wt) 
and hexane (12 mL) before the extract was 
applied. Analytes were subsequently eluted 
with hexane/DCM (12 mL; 9:1 wt/wt), evap-
orated to 0.2 mL, transferred to a GC-vial, 
further reduced to ~ 30 μL by gentle nitro-
gen flow, and recovery standard (octachloro-
naphtalene) was then added.
Instrumental analysis. Chlorinated pesti-
cides (excluding DDTs) (1-μL injection vol-
ume) were analyzed on an Agilent 7890A gas 
chromatograph (GC) (Agilent Technologies 
Europe, Boeblingen, Germany) equipped 
with a 5975c mass spectrometer (MS) (instru-
mental details were described previously by 
Hansen et al. 2010). We operated the MS 
in selected ion monitoring (SIM) and nega-
tive chemical ionization (NCI) modes at 
160°C. All POPs were analyzed with the GC 
temperature program used by Hansen et al. 
(2010) with the exception of the toxaphenes, 
which were analyzed separately under the 
following conditions: 70°C (3 min), 25°C 
min–1 to 180°C (0 min), and 15°C min–1 to 
280°C (5 min).
We analyzed PCBs and DDTs on the 
same GC as described above but with a 
Quattro Micro triple quadrupole MS (Waters 
Corporation, Manchester, UK). Injector set-
tings, GC column, carrier gas, and the tem-
perature program were as described above 
for pesticide analyses. The MS operated in 
MS/MS (MRM) mode with an electron ion-
ization source at 220°C. Argon (~ 0.23 Pa) 
was the collision gas. Information regarding 
ion transitions has been published previously 
(Pitarch et al. 2007).
Lipid determination. Analyses of tri-
glycerides, phospholipids, free cholesterol, 
and total cholesterol were determined enzy-
matically by Unilab Analyse AS, Tromsø, 
Norway, and a summed lipid concentration 
was calculated according to the equation 
 proposed by Akins et al. (1989).
Quality assurance and sample integrity. 
Quality control in POP and lipid analyses. 
To assess laboratory-derived sample con-
tamination and method accuracy and repro-
ducibility, we processed blanks (n = 9) and 
standard reference materials (SRMs) [SRM® 
1958 (n = 9) and 1957 (n = 9), both from 
the National Institute of Standards and 
Technology, Gaithersburg, MD, USA] along 
with the samples. Results for SRMs indicated 
analytical uncertainties within ± 20% of 
assigned values (within ± 5% for many com-
pounds). The NILU laboratory routinely par-
ticipates in the international AMAP Ring Test 
for Persistent Organic Pollutants in Human 
Serum and has performed well (within ± 20% 
of assigned values). Concomitantly, summed 
lipid concentrations in the test samples 
(n = 10) were within a 15% deviation from 
assigned values. [Ring test results are available 
from the Institut national de santé publique 
du Québec (2013).]
Mean recoveries of internal standards 
were 81%, 83%, 77%, 79%, and 56% for 
the 1979, 1986, 1994, 2001, and 2007 
samples, respectively. The internal standard 
recovery for the 2007 samples was low in one 
sample preparation batch (53% of the 2007 
samples); however, there was no association 
between recoveries and concentrations (data 
not shown). Recoveries were < 30% in three 
samples but were not excluded from statisti-
cal analyses because they did not constitute 
extreme observations nor did they deviate in 
model diagnostic plots. We rejected results 
when their isotopic mass ratios deviated by 
> 20% from the quantification standards. 
PCB-138/163, PCB-47/49, and PCB-28/31 
coeluted, and we summed their concentra-
tions. The limits of detection (LODs) were 
software-generated and corresponded to 
 signal-to-noise ratios of 3. Because consistent 
amounts of β–HCH and oxy-chlordane were 
measured in blanks, we subtracted mean blank 
concentrations for these compounds from 
all samples.
Estimation of desiccation and lipid degra-
da tion. To correct for spuriously high POP 
concentrations caused by evaporation during 
long-term storage, serum sodium (Na+) was 
measured and used to adjust lipid and POP 
concentrations. In samples with Na+ concen-
trations > 165 mmol/L (3% of samples), lipid 
and POP concentrations were adjusted by 
the ratio [Na+]mean/[Na+]sample (Krieger et al. 
1994). Na+ determinations were conducted at 
UNN using an ion-selective electrode method.
Total cholesterol and triglycerides were 
measured previously and, after adjusting cur-
rent results for desiccation, the past and current 
measurements deviated < 10% and correlations 
between the two measurements increased (data 
not shown).
Time-variant model simulations of PCBs 
in serum. Simulations of lipid-normalized 
serum concentrations of PCBs 118, 138, 153, 
and 180 for 1979, 1986, 1994, 2001, and 
2007 were carried out using the time-variant 
multimedia mechanistic CoZMoMAN model 
(Breivik et al. 2010). Previous CoZMoMAN 
model predictions for PCB concentrations 
and their temporal changes in women were 
within the ranges of measured concentrations 
(Breivik et al. 2010; Quinn and Wania 2012). 
Simulations were performed assuming time-
variant emission scenarios (Quinn et al. 2011). 
In general, model parameters were set as out-
lined by Breivik et al. (2010). Specifically, we 
assumed that trends and concentrations in 
the environment and food chains in Northern 
Norway are similar to the trends for Sweden 
and parts of Southeastern Norway that were 
used for model development, except for the 
dietary input parameters. We assumed that 
fish consumption in the population of older 
men from Northern Norway was higher 
than the original model input; therefore, we 
derived separate predictions based on average 
Norwegian fish consumption and three cate-
gories of higher fish consumption (for detailed 
information, see Supplemental Material, 
pp. 3–4 and Table S2). Model predictions 
for PCB-153 for the birth years 1930, 1935, 
1940, and 1945 (within the range of birth 
years of the study subjects) were obtained, 
assuming that either all of the birth cohorts 
had equal fish consumption or that fish con-
sumption differed among birth cohorts, with 
the earliest birth cohort consuming the most 
fish, and the latest cohort the least.
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Data treatment and statistical methods. 
We performed statistical analyses using R, 
version 2.13.1 (R Foundation for Statistical 
Computing, Vienna, Austria). Statistical 
significance was defined as p < 0.05. All 
POP results were lipid-adjusted and loge-
transformed in the statistical analyses. We 
excluded three samples from 1979 with high 
(> median + 2SD) and three samples from 
1994 with low lipid-adjusted concentrations 
(< median – 2SD) from statistical models in 
order to obtain the most appropriate model 
estimates; however, analyses including these 
samples and when performed on wet weight 
concentrations gave the same main results 
(data not shown). Lipid concentrations were 
missing for one sample, and thus the numbers 
of observations in the statistical analyses were 
51, 51, 45, 48, and 52 for the five time points.
We calculated summed POP concentra-
tions based on lipid-adjusted concentrations 
of compounds with > 60% detection; for 
values below LOD, we used the individual 
concentration estimates. Summary statistics 
for compounds with detection frequencies 
between 20% and 80% were calculated for 
each sampling year using the Kaplan–Meier 
method with the NADA package for R 
according to Helsel (2005).
Spearman’s ρ values were calculated for 
correlations. We used the Wilcoxon signed 
rank test to test differences in POP con-
centrations between sampling years and the 
Kruskal–Wallis rank sum test to test differ-
ences between birth year groups (categorized 
according to quartiles) in each sampling year.
We assessed APC effects for serum 
concentrations of PCB-153 using age and 
birth cohort groups categorized according 
to quartiles. We used mixed-effect models 
(lme4 package for R) that included a random 
slope for sampling year and subject-specific 
random terms (to allow subject-specific ran-
dom variation) to estimate periodic changes 
in PCB-153 concentrations and potential 
age-specific and birth cohort– specific effects. 
Despite collinearity, models used to assess 
APC effects must include all three time 
parameters (Palmore 1978); therefore, we 
used mixed-effects models with two param-
eters modeled as fixed effects and the third 
modeled as a random effect (Ding et al. 
2007). We also assessed body mass index as 
a fixed effect. Confidence intervals (CIs) for 
coefficients were obtained post hoc (glht in 
multcomp R package). We used Akaike’s 
information criterion (AIC) to compare mod-
els, and the nonparametric Friedman’s test to 
test differences across all measurements.
A graphical examination of APC effects 
for PCB-153 was carried out by plotting all six 
combinations of the three time factors accord-
ing to Ahacic et al. (2012) to assess longitudi-
nal patterns (i.e., concentrations according to 
birth cohort and sampling period or age), time-
lag patterns (concentrations according to age 
and sampling period or birth cohort), or cross-
sectional patterns (concentrations according to 
sampling period and age or birth cohort).
Results
Characteristics of study participants. Median 
ages at the first and last sampling were 43 and 
71 years, respectively (Table 1). The median 
birth year was 1936 (range, 1925–1950). 
The number of subjects in each age and birth 
cohort quartile is listed in Supplemental 
Material, Table S3.
Intraindividual changes in POP concen-
trations. Serum POP concentrations in each 
sampling year are presented for selected 
compounds in Figure 1 (see Supplemental 
Material, Table S4 for complete data for 
all analyzed POPs). The median individual 
decreases in summed POP concentrations in 
1986, 1994, 2001, and 2007 relative to the 
Table 1. Descriptive age statistics of study participants measured in 1979, 1986, 1994, 2001, and 2007 
(all male).
Age
1979 
(n = 51)
1986 
(n = 51)
1994 
(n = 45)
2001 
(n = 48)
2007 
(n = 52)
Median 43 50 58 65 71
Minimum 29 36 44 51 57
Maximum 54 61 69 76 82
Figure 1. Concentrations (ng/g lipid, loge scale) of selected POPs analyzed in repeated serum samples of men (n = 51, 51, 45, 48, and 52 in 1979, 1986, 1994, 2001, 
and 2007, respectively) from Northern Norway. p,p´-DDE, 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene. Parlar 50 represents toxaphenes, and trans-nonachlor the 
chlordanes. Boxes represent the 25th–75th percentiles, horizontal lines represent the median, whiskers indicate 1.5 times the length of the interquartile range 
above and below the 75th and 25th percentiles, respectively, and outliers are represented as data points. 
*p < 0.05, and **p < 0.001 for comparisons between pairs of consecutive sampling years.
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median concentration in 1979 were –22%, 
–52%, –54%, and –68%, respectively. 
Substantial declines were observed for all 
POPs with the exception of chlordanes [e.g., 
trans-nonachlor (Figure 1)]. Overall, decreases 
were observed from 1979 in concentrations 
of HCHs, HCB, c-chlordane, DDTs, and 
most penta- chlorinated PCBs (PCBs 99, 101, 
105, 118, and 123) and hexa- chlorinated 
PCBs (PCB 128, 141, 149, 153, and 167). 
Declining trends were exponential for many 
POPs, especially for p,p´-DDT (R2 = 0.78 
for fitted exponential trend line, data not 
shown). Concentrations of chlordanes (except 
c-chlordane), mirex, toxaphenes, and hepta- 
and octa- chlorinated PCBs (PCBs 170, 180, 
187, and 194) initially increased from 1979 to 
1986, and then declined in subsequent years. 
Concentration differences across all sampling 
years were significant for all POPs (Friedman’s 
test, p < 0.001); however, the absolute differ-
ences in the concentrations of chlordanes were 
small (e.g., 47 and 45 ng/g lipid adjusted for 
trans-nonachlor in 1979 and 2007, respec-
tively). Within individuals, the concentrations 
of most POPs were higher in 1979 than in 
2007, but time trends varied among individu-
als, as shown for PCB-153 (Figure 2; indi-
viduals grouped according to birth year).
Relative contributions of individual 
POPs to summed POP concentrations (as a 
percentage) are shown in Figure 3. Clearly, 
1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene 
(p,p´-DDE); PCBs 153, 138/163, and 180; 
and HCB were the most prominent (67–73% 
of sum in the different sampling years). 
p,p´-DDE/p,p´-DDT ratios were 12, 20, 29, 
41, and 55 for 1979, 1986, 1994, 2001, and 
2007, respectively.
POP correlations across sampling years. 
The correlations of concentrations (lipid-
adjusted) in any pair of consecutive sampling 
years increased across the study period for 
most compounds. Concentrations correlated 
significantly between 1986 and 1994, 1994 
and 2001, and 2001 and 2007 for PCB-153 
(ρ = 0.72, 0.80, and 0.87, respectively, all 
p < 0.001), and between all sampling years 
for p,p´-DDE (ρ = 0.44, 0.79, 0.87, and 
0.89 between 1979 and 1986, 1986, and 
1994, 1994 and 2001, and 2001 and 2007, 
 respectively, all p < 0.002).
Intercompound correlations. In 1979, cor-
relations were strong (ρ > 0.85) between PCB-
153 and oxy-chlordane, mirex, and PCBs 99, 
118, 138/163, 156, 157, 167, 170, 180, 183, 
187, 189, and 194. The correlations between 
PCB-153 and other POPs were also strong 
in the subsequent sampling years (ρ > 0.85; 
n = 13, 8, 10, and 9 compounds for 1986, 
1994, 2001, and 2007, respectively), yet 
slightly weaker over time.
Predicted PCB concentrations. Measured 
and predicted concentrations (nanograms 
per gram lipid) of PCBs 118, 138, 153, and 
180 from CoZMoMAN simulations for a 
1935 birth cohort of men are presented in 
Supplemental Material, Figure S1 for the 
5 sampling years according to four different 
assumptions regarding fish consumption. 
Model predictions were generally consistent 
with measured concentrations, especially for 
PCBs 153 and 180, but overestimated con-
centrations of PCB-118 and underestimated 
concentrations of PCB-138. Predicted trends 
(assuming equal fish consumption among 
birth cohorts) for PCB-153 concentrations 
for men born in 1930, 1940, and 1945 (see 
Supplemental Material, Figure S2) showed 
similar trends among birth years.
Estimated APC effects on changes in PCB-
153 concentrations. Estimates from mixed-
effect models of PCB-153 concentrations in 
the different sampling years, with age, period, 
Figure 2. Individual trend lines for PCB-153 serum concentrations (ng/g lipid) measured in 1979, 1986, 
1994, 2001, and 2007 in 53 men from Northern Norway, according to birth year quartile. (A) 1925–1934, 
(B) 1934–1936, (C) 1936–1941, and (D) 1941–1950.
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and birth cohort modeled as fixed predictors 
or as random effects (accounting for  subject–
specific variation) are shown in Table 2. The 
best fitting model included period and birth 
cohort as predictors, and age as a random 
effect. Estimates for the period effects (i.e., 
changes according to sampling year) were 
generally consistent among models. Including 
body mass index for all sampling years did 
not improve the model (data not shown). 
Additional models that specified inter actions 
or nonlinear effects (as product or cubic terms, 
respectively) were not possible (they did 
not converge).
Figure 4 shows selected plots of a graphical 
examination of APC effects. The period effect 
is apparent as decreasing PCB-153 concentra-
tions across the sampling years and as subjects 
aged (Figure 4A,B). Although differences in 
PCB-153 concentrations among birth cohort 
quartiles across sampling years were not sig-
nificant for some sampling years (Figure 4A), 
the most recently born cohort (1941–1950) 
appeared to have the lowest concentrations, 
and the earliest cohort (1925–1934) had the 
highest. Within sampling years, concentra-
tions increased with age and decreased in 
more recent birth cohorts (Figure 4C; see also 
Supplemental Material, Figure S3C). Finally, 
within age groups, concentrations decreased 
according to sampling period and birth year 
(see Supplemental Material, Figure S3A 
and B, respectively). Overall, the graphical 
examination suggests clear period effects and 
additional birth cohort effects, whereas age 
effects appear relatively weak. APC patterns 
based on predicted PCB-153 concentrations 
(Figure 4D–F; see also Supplemental Material, 
Figure S3D–F) were generally consistent with 
patterns based on measured values.
Discussion
Intraindividual changes in POP concen-
trations from 1979 to 2007. Overall, our 
findings suggest that POP concentrations 
decreased during 1979–2007 in men from 
Northern Norway. Average summed POP 
concentrations in 2007 were one third of con-
centrations measured in 1979. The majority 
of POP concentrations declined from 1979, 
although median concentrations of some 
compounds peaked in 1986 (e.g., PCBs 170, 
180, and 194). Peak PCB-153 concentrations 
were measured in 1979 and 1986, confirm-
ing this period as the years of highest human 
exposure, a feature which was also reproduced 
by CoZMoMAN (see Supplemental Material, 
Figure S1). We also observed large individ-
ual variability during these years, as could 
be expected.
The downward trends in serum concentra-
tions likely reflect declining environ mental 
concentrations due to reduced emissions 
during the same time period. This is in 
accordance with previous findings for envi-
ronmental and human POP concentrations 
in Europe (AMAP 1998; Bignert et al. 1998). 
Our findings indicate that serum concentra-
tions of DDTs peaked before PCBs, which is 
consistent with emission estimates for DDTs 
(Li and Macdonald 2005) and PCBs (Breivik 
et al. 2010). The delay in global emissions 
of PCBs could be due to the long lifetime of 
PCB-containing products (e.g., transformers, 
capacitors) (Breivik et al. 2007). The declines 
of many POPs, especially p,p´-DDT, were 
exponential and indicated nonlinear rates of 
decrease across the study period. The concen-
trations of some compounds were unchanged 
or decreased only slightly (chlordanes and 
mirex), emphasizing the need to include 
these compounds in monitoring studies. 
Correlations of POPs in any pair of consecu-
tive sampling years became stronger during 
the study period, possibly due to reduced 
 concentrations and reduced variability of 
exposures over time.
Our results suggest that regulatory mea-
sures to reduce the manufacture and use of 
POPs during the 1970s and 1980s had rapid 
impacts not only on environmental concentra-
tions (AMAP 1998), but also on human expo-
sures. Substantial reductions in human intake 
rates relative to elimination rates are suggested.
PCB-153 concentrations and aAPC effects. 
Time period had the strongest influence on 
PCB-153 concentrations based on both the 
graphical examination and the mixed-effect 
analyses. Although the range of birth years 
(1925–1950) was relatively narrow, the mixed-
effect analyses also suggested an additional 
influence of birth cohort. This may reflect dif-
ferences in cumulative exposure and dietary 
patterns among birth cohorts, consistent with 
associations between PCB-153 and age or 
birth cohort that have been reported based on 
cross-sectional studies (Bjerregaard et al. 2001; 
Hardell et al. 2010; Perry et al. 2005; Rylander 
et al. 1997; Wolff et al. 2005, 2007).
Changes in dietary intakes (Quinn et al. 
2012) and body mass (Wolff et al. 2007) 
must also be considered when evaluating time 
trends in human POP concentrations. When 
model simulations included the assumption 
Table 2. Mixed-effect model estimatesa [coefficients (95% CIs)] of changes in PCB-153 concentrations (ng/g lipid) during 1979–2007 among 53 men from 
Northern Norway, with age, calendar period, and birth cohort as predictors.
Predictor
Model 1: period only 
(fixed effects)
Model 2: period and age  
(fixed effects)
Model 3: period and age 
(fixed effects) plus birth 
cohort (random effect)b
Model 4: period and birth 
cohort (fixed effects)
Model 5: period and birth 
cohort (fixed effects) plus 
age (random effect)b
Periodc
1979 Referent Referent Referent Referent Referent
1986 51 (–68, 221) 72 (–69, 284) 82 (–71, 311) 67 (–98, 326) 22 (–104, 202)
1994 –85 (–156, 12) –66 (–159, 73) –82 (–175, 54) –82 (–179, 62) –117 (–191, –16)
2001 –95 (–163, –2) –76 (–172, 74) –93 (–189, 52) –84 (–181, 57) –119 (–194, –17)
2007 –160 (–210, –90) –150 (–224, –30) –175 (–245, –65) –163 (–238, –52) –190 (–251, –103)
Age (years)d
29–47 — Referent Referent — —
47–57 — –32 (–122, 94) –31 (–122, 94) — —
57–66 — –35 (–138, 117) –27 (–133, 126) — —
66–82 — –24 (–144, 167) –4 (–129, 184) — —
Birth cohorte
1925–1934 — — — Referent Referent
1934–1936 — — — –73 (–210, 170) –61 (–199, 173)
1936–1941 — — — –24 (–180, 249) –17 (–171, 244)
1941–1950 — — — –139 (–246, 50) –149 (–251, 26)
AICf 154 157 176 151 137
All models included a subject-specific random term and a random slope for sampling year; age and birth cohort variables were divided into quartiles. 
aCoefficients are backtransformed from log-estimates of fixed effect variables and are in units of ng/g lipid. bVariables were added to models as random terms to allow for random 
variation in individuals. cCoefficients express change for PCB-153 concentrations (ng/g lipid) across sampling years, with 1979 as the reference period category. dCoefficients express 
change in PCB-153 concentrations (ng/g lipid) across age quartiles, with the youngest age group (29–47 years) as the reference category. eCoefficients express change in PCB-153 
concentrations (ng/g lipid) across birth cohort quartiles with the oldest birth cohort group (1925–1934) as the reference category. fLower Akaike’s information criterion numbers indi-
cate better model fit when comparing models.
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of higher fish consumption in earlier birth 
cohorts (in accordance with the available 
dietary information and inter generational 
dietary differences in Quinn et al. 2012), we 
observed consistent patterns of predicted and 
observed PCB-153 concentrations according 
to birth cohort (Figure 4A,D). Although pre-
dictions were not based on individual dietary 
information, CoZMoMAN model estimates 
were consistent with observed birth cohort 
patterns. This supports the use of mechanistic 
modeling in hypothesis testing and illustrates 
that an understanding of temporal trends in 
emissions and of confounded time factors is 
relevant for POP monitoring studies.
Changes in relative concentrations of POPs. 
The relative concentrations of POPs in human 
serum changed over time, both between and 
within POP groups. The majority of POPs 
evaluated were highly correlated with PCB-153 
concentrations during all sampling years, 
supporting the use of PCB-153 as a marker 
compound for many legacy POPs, although 
it is important to note that correlations with 
PCB-153 concentrations weakened over time.
Proportions relative to the sum of all POPs 
decreased for p,p´-DDE (from 37% in 1979 
to 21% in 2007) and increased for the sum of 
PCB 138, 153, and 180 (from 30% in 1979 to 
44% in 2007). A steeper decline in concentra-
tions for p,p´-DDE compared with PCB-153 
has been reported previously based on human 
longitudinal studies (Hagmar et al. 2006; 
Hovinga et al. 1992; Vo et al. 2008). Because 
the p,p´-DDE/p,p´-DDT ratio is sensitive 
to recent exposure to p,p´-DDT (Anda et al. 
2007), its increase from 12 in 1979 to 55 in 
2007 suggests that exposure to p,p´-DDT was 
markedly reduced. The relative contribution 
of PCBs (and especially the higher– chlorinated 
congeners) to summed POPs increased, and 
thus PCBs might be expected to dominate 
future organochlorine POP burdens. Overall, 
the relative changes in POP concentrations 
may be explained by differences in emission 
histories, environmental persistence, exposure 
sources, and elimination rates.
Comparisons to other longitudinal studies. 
Clearly, age distribution and time of sam-
pling relative to historic POP emissions must 
be considered when comparing longitudinal 
POP trends. The concentrations and temporal 
changes in PCB-153, p,p´-DDE, and HCB in 
our study population were similar to findings 
for younger Swedish men sampled in 1991 
and 2001 (Hagmar et al. 2006). Measured 
concentrations were lower and peaked later in 
our study population than POPs concentra-
tions measured in two longitudinal cohorts 
in the Great Lakes area [Hovinga et al. 1992 
(sampled in 1982 and 1989); Tee et al. 
2003 (sampled in 1980, 1990, and 1994)]. 
These similarities and differences may reflect 
geographical differences in environmental 
exposures during the same time period, in 
addition to different dietary patterns.
Evaluation of time-variant model pre-
dictions. We challenged the CoZMoMAN 
mechanistic model with observations in order 
to evaluate its performance. Overall, the mod-
el’s predictions were in reasonable agreement 
with temporal changes in median measured 
concentrations from 1979 to 2007, especially 
for PCB-153. The observed over estimation 
of PCB-118 by the CoZMoMAN model has 
Figure 4. APC plots showing observed (A–C) and predicted serum PCB-153 concentrations (D–F, using the CoZMoMAN model assuming higher fish consumption 
in earlier birth cohorts). A and D show longitudinal variation among birth cohorts according to sampling period, B and E show longitudinal variation among birth 
cohorts according to age quartile (Q), and C and F cross-sectional variation among sampling periods according to age quartile. Data points indicate ng/g lipid-
adjusted concentrations (median concentrations are displayed in A–C). Differences between birth cohorts in A were significant in 1986 and 2007 (Kruskal–Wallis 
rank sum test, p < 0.05).
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also been reported by Czub and McLachlan 
(2004), who suggested that it could be due to 
an incorrect assumption of zero metabolism 
of this congener in humans. The coelution of 
PCB-138 and PCB-163 in chromatograms is 
likely the reason for the apparent underestima-
tion of PCB-138. The model did predict an 
initial increase of PCB-180 during the early 
1980s consistent with our empirical results, 
although the observed decline afterwards was 
slightly steeper than predicted.
Study limitations. Although statistical 
approaches to APC effects have been much 
discussed in the literature, no consensus has 
been reached (Glenn 2003). Currently, suit-
able p-values in mixed-effect models cannot be 
calculated in the statistical software. Potential 
interactions between the time factors could 
not be considered in the mixed-effect model 
analysis, and our ability to examine APC 
effects was limited by the small numbers of 
men in some age groups.
Individual dietary information was not 
available for the model parameterization; there-
fore, we used estimates of average and high fish 
consumption in Norwegian populations to 
reflect the potential range of fish consumption 
in the study population instead.
Conclusions
Longitudinal declines in legacy POPs in 
serum samples from Norwegian men dur-
ing 1979–2007 are consistent with reduced 
environmental exposures in this period. Our 
adaptation of methods to assess APC effects 
based on biomonitoring data is novel and sug-
gests that calendar time (i.e., period effects) 
had a major influence on observed concentra-
tions, although birth cohort differences were 
also indicated. Predicted concentrations and 
time trends for PCB-153 were consistent with 
those measured. The use of APC analysis and 
emission-based modeling in human biomoni-
toring enhances our understanding of the rela-
tionship between temporal trends in human 
POP burdens and historical emissions.
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